8 research outputs found

    Effects of Rimonabant on learning and memory of rats with olfactory bulbectomy

    Get PDF
    Olfactory bulbectomy (OBX) is an experimental model of depression, which has recently been used as a model of Alzheimer's disease due to the development of neurodegenerative changes in the brain. The OBX model in rodents is accompanied by biochemical, morphological and structural changes in the brain, as well as by many behavioral changes. A common finding in the OBX model are memory deficits, which are present in both depressive disorders and neurodegenerative diseases. There is evidence that the memory-impairing effect of cannabinoids is associated with activation of the cannabinoid CB1 receptors in the brain. The aim of the present study was to investigate the effects of the CB1 antagonist Rimonabant (SR 141716A) administered intragastrically daily for 14 days on the memory processes of OBX rats, tested in a passive avoidance (PA) paradigm. Rimonabant was administered to OBX rats, divided into three experimental groups: before OBX; immediately after OBX (1-14 days); with the presence of a depressive-like state (14-28 days after OBX).Β  Rimonabant showed a tendency to improve the learning and memory of sham-operated controls, whereas no significant change in the behavioral responses was observed upon administration 14 days before OBX. However, Rimonabant, administered immediately after OBX completely prevented the development of memory deficit in a PA test, while its administration 14-28 days after OBX ameliorated the memory disturbances induced by bulbectomy.The results indicate that the CB1 antagonist Rimonabant may ameliorate the development of a memory deficit in OBX rats

    Wine as a medicine in ancient times

    Get PDF
    The history of wine use as a medicine dates back to antiquity. However, it has been rediscovered and reliably confirmed by current medical research. It is believed that wine is among the first documented remedies known and used by humans dating back to a period before 5000 BC. Preserved to date evidence of the medical use of wine in ancient times is very limited and is related to the development of different cultures and ancient civilizations. The article chronicles the more important periods of the history of the use of wine for medical (healing and prophylactic) purposes.The first evidence dates back to the time of the Mesopotamian culture, when the world's oldest Sumerian Pharmacopoeia - clay tiles, some of which contain wine prescriptions for therapy, was created. The next important documentary evidence is found in the Sino-Tibetan Pharmacopoeia, the Egyptian Medical Papyri, the Bible, the Sacred Book of the Jews Talmud, and the ancient Indian medical texts of Ayurveda. In ancient Greece, the first evidence of the healing effects of wine is found in the two poems of Homer Iliad and Odyssey. With the development of medical knowledge at the time of Hippocrates, the therapeutic use of wine expanded. Hippocrates included wine in the diet of almost all diseases, especially during the recovery period. Afterwards, the principles of wine therapy continued to be topical, although they were the subject of a heated debate during the Greco-Roman period, Galen's era, and even the Byzantine era, when the influence of Arab medicine began to manifest itself more and more

    Neurophysiological mechanisms of sweet taste preference

    Get PDF
    Food intake regulation is a complex process influenced by the dynamic interplay between two systemsβ€”homeostatic and hedonic regulation systems. Homeostatic regulation depends on the information from the gastrointestinal tract, adipose tissue, n. vagus, while hedonic regulation is primarily controlled by reward processes. This is multifactor process that creates and establishes specific patterns of eating behavior, often associated with certain taste preferences

    Influence of the endocannabinoid system on memory processes

    Get PDF
    The endocannabinoid system (ECS) is a lipid signaling system, which consists of the endocannabinoids (EC) anandamide (AEA) and 2-arachidonylglycerol (2-AG), the cannabinoid receptors (CB1 and CB2), and the enzymes that regulate their production and degradation. AEA and 2-AG are lipid compounds derived presynaptically from the degradation of membrane phospholipids and act as key modulators on synaptic transmission. This article presents accumulated data on the mechanisms by which ECS affects learning and memory. Substances that modulate the activity of ECS have impact on different phases of memory formation through direct and indirect influences. Studies show contradictory results on the role of the ECS in learning and memory processes

    MODULATORY EFFECT OF CANNABINOID LIGANDS ON THE ANXIETY-LIKE BEHAVIOR OF BULBECTOMIZED RATS

    Get PDF
    Purpose: The endocannabinoid system is considered a key regulatory system in anxiety behavior. The aim of the present study was to examine the effects of intracerebroventricularly (i.c.v.) injected cannabinoid ligands on the anxiety-like behavior of rats with a model of depression. Material/Methods: The olfactory bulbectomized rat (OBX) is a well-established experimental model of depression. The OBX model exhibits neurochemical changes that are very similar to those seen in patients with depression. CB1 receptor agonist HU-210 and CB1 receptor antagonist SR 141716A were injected i.c.v. in OBX rats, and the anxiety-related behavior of the rats was measured in an elevated plus-maze (EPM) test. Results: OBX rats showed an increased anxiety-like behavior at the EPM test. HU-210 produced an anxiolytic-like effect and alleviated the OBX-induced anxiety, while SR 141716A failed to produce effects on the behavior of OBX rats. Conclusions: The results suggest that CB1 receptors may be involved in the modulation of anxiety-related behavior in OBX rats

    Imprinting: nature and manifestations in humans

    Get PDF
    Imprinting (filial and sexual) is a process of learning a key stimulus or complex stimuli during early critical periods of development, further determining the implementation of innate forms of behavior. The present literature review summarizes earlier and current data regarding the neurophysiology and neurochemistry of imprinting, and its potential benefits. Although, according to the classic views, imprinting is inherent in birds and some mammals, there are reasons to assume that imprinting or similar forms of learning also exist in humans. In the context of this assumption, the mechanisms of newborn-mother bonding and of assortative mate choice in humans are discussed

    Influence of Subchronically Applied Ligands on the Cannabinoid Receptors on Learning and Memory Processes in Olfactory Bulbectomized Rats // ВлияниС Π½Π° субхронично въвСТдани Π»ΠΈΠ³Π°Π½Π΄ΠΈ Π½Π° ΠΊΠ°Π½Π°Π±ΠΈΠ½ΠΎΠΈΠ΄Π½ΠΈΡ‚Π΅ Ρ€Π΅Ρ†Π΅ΠΏΡ‚ΠΎΡ€ΠΈ Π²ΡŠΡ€Ρ…Ρƒ ΠΎΠ±ΡƒΡ‡ΠΈΡ‚Π΅Π»Π½ΠΈΡ‚Π΅ ΠΈ ΠΏΠ°ΠΌΠ΅Ρ‚ΠΎΠ²ΠΈ процСси Π½Π° ΠΏΠ»ΡŠΡ…ΠΎΠ²Π΅ с ΠΎΠ»Ρ„Π°ΠΊΡ‚ΠΎΡ€Π½Π° булбСктомия

    No full text
    The main task of the present study is, by using various ways of applications: i.c.v. and intragastric, in the conditions of the subchronic experiment (7 and 14 days), to evaluate the effects of ligands on cannabinoid receptors on learning and memory processes in rats with OBX-model. Based on the results of our study, we can conclude that the investigation of the influence of subchronically applied ligands of cannabinoid receptors in rats with a model of olfactory bulbectomy is a specific contribution to revealing the role of CB-receptors in the development of memory deficits, accompanying this model. Comparing the effects in OBX- and Sham-operated rats allows a distinct evaluation of the physiologic importance of the CB-receptors for the cognitive processes in the organism. The results and conclusions underline the necessity of accumulating more data for the effects and investigation of the ECS manipulation in specific conditions, thus widening the potential therapeutic approach to treat depression and Alzheimer’s disease. The study presents additional details on the interrelation between the cognitive and depressive symptoms and the ECS influence on cognitive and emotional processes with pathologic disorders accompanied by a cognitive effect, like depression, Alzheimer’s disease, etc.ΠžΡΠ½ΠΎΠ²Π½Π°Ρ‚Π° Π·Π°Π΄Π°Ρ‡Π° Π½Π° настоящото изслСдванС Π΅ Ρ‡Ρ€Π΅Π· ΠΈΠ·ΠΏΠΎΠ»Π·Π²Π°Π½Π΅ Π½Π° Ρ€Π°Π·Π»ΠΈΡ‡Π½ΠΈ Π½Π°Ρ‡ΠΈΠ½ΠΈ Π½Π° субхронично ΠΏΡ€ΠΈΠ»ΠΎΠΆΠ΅Π½ΠΈΠ΅: i.c.v. ΠΈ интрагастрално (7 ΠΈ 14 Π΄Π½ΠΈ), Π΄Π° сС оцСнят Π΅Ρ„Π΅ΠΊΡ‚ΠΈΡ‚Π΅ Π½Π° Π»ΠΈΠ³Π°Π½Π΄ΠΈΡ‚Π΅ Π½Π° ΠΊΠ°Π½Π°Π±ΠΈΠ½ΠΎΠΈΠ΄Π½ΠΈΡ‚Π΅ Ρ€Π΅Ρ†Π΅ΠΏΡ‚ΠΎΡ€ΠΈ Π²ΡŠΡ€Ρ…Ρƒ процСситС Π½Π° ΠΎΠ±ΡƒΡ‡Π΅Π½ΠΈΠ΅ ΠΈ ΠΏΠ°ΠΌΠ΅Ρ‚ ΠΏΡ€ΠΈ ΠΏΠ»ΡŠΡ…ΠΎΠ²Π΅ с OBX-ΠΌΠΎΠ΄Π΅Π». Π’ΡŠΠ· основа Π½Π° цялото изслСдванС ΠΌΠΎΠΆΠ΅ΠΌ Π΄Π° ΠΎΠ±ΠΎΠ±Ρ‰ΠΈΠΌ, Ρ‡Π΅ ΠΏΡ€ΠΎΡƒΡ‡Π²Π°Π½Π΅Ρ‚ΠΎ Π½Π° влияниСто Π½Π° субхронично Π²ΡŠΠ²Π΅ΠΆΠ΄Π°Π½ΠΈΡ‚Π΅ Π»ΠΈΠ³Π°Π½Π΄ΠΈ Π½Π° ΠΊΠ°Π½Π°Π±ΠΈΠ½ΠΎΠΈΠ΄Π½ΠΈΡ‚Π΅ Ρ€Π΅Ρ†Π΅ΠΏΡ‚ΠΎΡ€ΠΈ Π½Π° ΠΏΠ»ΡŠΡ…ΠΎΠ²Π΅ с ΠΌΠΎΠ΄Π΅Π» ΠΎΠ»Ρ„Π°ΠΊΡ‚ΠΎΡ€Π½Π° булбСктомия, допринася Π·Π° Ρ€Π°Π·ΠΊΡ€ΠΈΠ²Π°Π½Π΅ ролята Π½Π° Π‘Π’-Ρ€Π΅Ρ†Π΅ΠΏΡ‚ΠΎΡ€ΠΈΡ‚Π΅ Π² Ρ€Π°Π·Π²ΠΈΡ‚ΠΈΠ΅Ρ‚ΠΎ Π½Π° ΠΏΠ°ΠΌΠ΅Ρ‚ΠΎΠ²ΠΈΡ‚Π΅ Π΄Π΅Ρ„ΠΈΡ†ΠΈΡ‚ΠΈ, ΡΡŠΠΏΡŠΡ‚ΡΡ‚Π²Π°Ρ‰ΠΈ ΠΌΠΎΠ΄Π΅Π»Π°. БравняванСто Π½Π° Π΅Ρ„Π΅ΠΊΡ‚ΠΈΡ‚Π΅ Π½Π° OBX- ΠΈ Sham-ΠΎΠΏΠ΅Ρ€ΠΈΡ€Π°Π½ΠΈ ΠΏΠ»ΡŠΡ…ΠΎΠ²Π΅ позволява Π΄Π° сС ΠΎΡ†Π΅Π½ΠΈ Ρ„ΠΈΠ·ΠΈΠΎΠ»ΠΎΠ³ΠΈΡ‡Π½ΠΎΡ‚ΠΎ Π·Π½Π°Ρ‡Π΅Π½ΠΈΠ΅ Π½Π° CB-Ρ€Π΅Ρ†Π΅ΠΏΡ‚ΠΎΡ€ΠΈΡ‚Π΅ Π·Π° ΠΊΠΎΠ³Π½ΠΈΡ‚ΠΈΠ²Π½ΠΈΡ‚Π΅ процСси. Π Π΅Π·ΡƒΠ»Ρ‚Π°Ρ‚ΠΈΡ‚Π΅ ΠΈ Π·Π°ΠΊΠ»ΡŽΡ‡Π΅Π½ΠΈΡΡ‚Π° ΠΏΠΎΠ΄Ρ‡Π΅Ρ€Ρ‚Π°Π²Π°Ρ‚ нСобходимостта ΠΎΡ‚ Π½Π°Ρ‚Ρ€ΡƒΠΏΠ²Π°Π½Π΅ Π½Π° ΠΏΠΎΠ²Π΅Ρ‡Π΅ Π΄Π°Π½Π½ΠΈ Π·Π° Π΅Ρ„Π΅ΠΊΡ‚ΠΈΡ‚Π΅ ΠΎΡ‚ ΠΌΠ°Π½ΠΈΠΏΡƒΠ»ΠΈΡ€Π°Π½Π΅Ρ‚ΠΎ Π½Π° Π΅Π½Π΄ΠΎΠΊΠ°Π½Π°Π±ΠΈΠ½ΠΎΠΈΠ΄Π½Π°Ρ‚Π° систСма ΠΏΡ€ΠΈ спСцифични условия, ΠΊΠ°Ρ‚ΠΎ ΠΏΠΎ Ρ‚ΠΎΠ·ΠΈ Π½Π°Ρ‡ΠΈΠ½ Π±ΠΈ могъл Π΄Π° сС Ρ€Π°Π·ΡˆΠΈΡ€ΠΈ потСнциалният Ρ‚Π΅Ρ€Π°ΠΏΠ΅Π²Ρ‚ΠΈΡ‡Π΅Π½ ΠΏΠΎΠ΄Ρ…ΠΎΠ΄ Π·Π° Π»Π΅Ρ‡Π΅Π½ΠΈΠ΅ Π½Π° дСпрСсията ΠΈ болСстта Π½Π° АлцхаймСр. Π˜Π·ΡΠ»Π΅Π΄Π²Π°Π½Π΅Ρ‚ΠΎ прСдставя Π΄Π΅Ρ‚Π°ΠΉΠ»ΠΈ Π·Π° изясняванС Π½Π° Π²Π·Π°ΠΈΠΌΠΎΠ²Ρ€ΡŠΠ·ΠΊΠ°Ρ‚Π° ΠΌΠ΅ΠΆΠ΄Ρƒ ΠΊΠΎΠ³Π½ΠΈΡ‚ΠΈΠ²Π½ΠΈΡ‚Π΅ ΠΈ дСпрСсивнитС симптоми, ΠΊΠ°ΠΊΡ‚ΠΎ ΠΈ ΠΏΠΎ ΠΎΡ‚Π½ΠΎΡˆΠ΅Π½ΠΈΠ΅ Π½Π° Π΅Π½Π΄ΠΎΠΊΠ°Π½Π°Π±ΠΈΠ½ΠΎΠΈΠ΄Π½ΠΎΡ‚ΠΎ влияниС Π²ΡŠΡ€Ρ…Ρƒ ΠΊΠΎΠ³Π½ΠΈΡ‚ΠΈΠ²Π½ΠΈΡ‚Π΅ ΠΈ Π΅ΠΌΠΎΡ†ΠΈΠΎΠ½Π°Π»Π½ΠΈ процСси ΠΏΡ€ΠΈ заболявания, ΠΊΠ°Ρ‚ΠΎ дСпрСсия ΠΈ болСст Π½Π° АлцхаймСр
    corecore